Commentary
Management of Pediatric Psoriasis: What's True, What's Left to Do?
Kelly M. Cordoro M.D.,
Corresponding Author
Kelly M. Cordoro M.D.
Department of Dermatology, University of California, San Francisco, San Francisco, California
Address correspondence to Kelly M. Cordoro, M.D., Department of Dermatology, University of California San Francisco, 1701 Divisadero Street, 3rd Floor San Francisco, CA 94115, or e-mail:
[email protected].
Search for more papers by this author
Kelly M. Cordoro M.D.,
Corresponding Author
Kelly M. Cordoro M.D.
Department of Dermatology, University of California, San Francisco, San Francisco, California
Address correspondence to Kelly M. Cordoro, M.D., Department of Dermatology, University of California San Francisco, 1701 Divisadero Street, 3rd Floor San Francisco, CA 94115, or e-mail:
[email protected].
Search for more papers by this author
First published: 21 March 2016
No abstract is available for this article.
References
- 1Klufas DM, Wald JM and Strober BE. Treatment of moderate to severe pediatric psoriasis: a retrospective case series. Pediatr Dermatol 2016; 33: 142–149.
- 2Vogel SA, Yentzer B, Davis SA et al. Trends in pediatric psoriasis outpatient health care delivery in the United States. Arch Dermatol 2012; 148: 66–71.
- 3Posso-De Los Rios CJ, Pope E, Lara-Corrales I. A systematic review of systemic medications for pustular psoriasis in pediatrics. Pediatr Dermatol 2014; 31: 430–439.
- 4Boehncke WH, Boehncke S, Tobin AM et al. The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 2011; 20: 303–307.
- 5Onoufriadis A, Simpson MA, Pink AE et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet 2011; 89: 432–437.
- 6Talamonti M, Botti E, Galluzzo M et al. Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab. Br J Dermatol 2013; 169: 458–463.
- 7Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015; 372: 793–795.
